Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cofact reversal of dabigatran and rivaroxaban anticoagulation in healthy volunteers
NL-OMON22423Recruiting
- Sponsor
- Prof. dr. M.M. Levi, Academic Medical Centre of Amsterdam
- Start
- Apr 2010
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial of Human prothrombin complex, dabigatran and rivaroxaban in anticoagulant reversal (4 arms), sponsored by Prof. dr. M.M. Levi, Academic Medical Centre of Amsterdam. Primary endpoints: Activation and inhibition of coagulation and Coagulation assays over time. Started Apr 2010; status: recruiting.
02
Drugs
Human prothrombin complexdabigatranrivaroxaban
03
Conditions
anticoagulant reversal
Beyond the preview
Go deeper on NL-OMON22423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22423.